Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study

Clinical trial NCT05935358 · RECRUITING

Trial details

NCT number: NCT05935358
Sponsor: Octapharma
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Severe Hemophilia A

Start date: 2023-11-28
Primary completion: 2026-08-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.